K. Sawaguchi

Growth potential of endometrial cancers assessed by a Ki-67 Ag/DNA dual-color flow-cytometric assay.

T. Masuda, H. Yabushita, K. Sawaguchi, 1992, Gynecologic oncology.

Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.

M. Kawai, H. Yabushita, K. Sawaguchi, 2001, Gynecologic oncology.

The Association of Transforming Growth Factor‐β1 with Myometrial Invasion of Endometrial Carcinomas through Effects on Matrix Metalloproteinase

H. Yabushita, K. Sawaguchi, M. Noguchi, 2000, The journal of obstetrics and gynaecology research.

Usefulness of collagen gel droplet embedded culture drug sensitivity testing in ovarian cancer.

M. Komiyama, Takeshi Mori, Y. Noguchi, 2004, Oncology reports.

Immunohistochemical assessment of the growth fraction in cervical cancers using the monoclonal antibody Ki-67; relationship to the clinical stage, histologic type and DNA content.

T. Masuda, H. Yabushita, K. Sawaguchi, 2010, Asia-Oceania journal of obstetrics and gynaecology.

Identification of immunosuppressive factors in normal pregnant serum affecting antibody dependent cell-mediated cytotoxicity.

Y. Itoh, H. Yabushita, K. Sawaguchi, 2010, Asia-Oceania journal of obstetrics and gynaecology.

Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.

H. Yabushita, K. Sawaguchi, M. Noguchi, 2003, Oncology reports.

Establishment and characterization of a new human cell-line (AMOC-2) derived from a serous adenocarcinoma of ovary.

H. Yabushita, K. Sawaguchi, M. Noguchi, 1989, Nihon Sanka Fujinka Gakkai zasshi.

Differences in the mechanisms of production and release of SCC-Ag and CEA from an established uterine cervical carcinoma cell line (AMCC-1).

H. Yabushita, K. Sawaguchi, M. Noguchi, 2010, Asia-Oceania journal of obstetrics and gynaecology.